Upon exposure to the bacterial chemotactic peptide fMet-Leu-Phe, human neutrophils release lysozyme and generate superoxide anions (20 -) 
INTRODUCTION
Human neutrophils play a key role in the host defence against bacterial infections, with bactericidal activity depending largely on lysosomal enzyme release and on NADPH-oxidase-catalysed superoxide (02'-) formation (Rossi, 1986; Malech & Gallin, 1987) . The bacterial chemotactic peptide N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMet-Leu-Phe) binds to formyl peptide receptors and activates phospholipase C, catalysing polyphosphoinositide degradation to diacylglycerol and inositol phosphates (Rossi, 1986) . Diacylglycerol activates protein kinase C, and inositol trisphosphate mobilizes intracellular Ca2l. Formyl peptide receptors interact with guanine-nucleotide-binding proteins (G-proteins), whose ADP-ribosylation by pertussis toxin prevents cell activation. The mechanism by which chemotactic peptides activate NADPH oxidase may involve protein kinase C, Ca2+ mobilization and direct stimulation by G-proteins (Rossi, 1986; Seifert et al., 1986; Seifert & Schultz, 1987a,b) .
The outer cell wall of Gram-negative bacteria contains lipopolysaccharide and lipoprotein (Braun, 1975; Guthrie et al., 1984; Forehand et al., 1989) . Lipoproteins and synthetic analogues derived from the N-terminus of lipoproteins are potent activators of macrophages and lymphocytes (Melchers et al., 1975; Resch & Bessler, 1981; Bessler et al., 1985; Hoffmann et al., 1988; Hauschildt et al., 1989) . Lipopolysaccharide primes neutrophils for enhanced O2.-formation (Guthrie et al., 1984; Forehand et al., 1989) , but the effects of lipoproteins on 02.-formation have not yet been studied. The synthetic lipopeptide 4] contains two ester-bound and one amidebound palmitoyl residues attached to S-glyceryl-cysteine (Fig. 1 ). In the murine macrophage cell line P388D1, but not in murine B-lymphocytes or bone-marrow-derived macrophages, synthetic lipopeptides induce polyphosphoinositide degradation and translocation of protein kinase C (Hauschildt et al., 1988; Steffens et al., 1989) . Recently it has been shown that synthetic viral § To whom correspondence and reprint requests should be sent.
N-palmitoyl-S-[2,3-bis(palmitoyloxy)-(2RS)-propyl]-(R)-cysteinyl-(S)-seryl-(S)-lysyl-(S)-lysyl-(S)-lysyl-(S)-lysine
peptides covalently linked to lipopeptides, such as the influenza virus itself, induce high-affinity cytotoxic T-lymphocytes in vivo (Deres et al., 1989) . We report here that PaM3Cys-Ser-(Lys)4 activates 02.-formation and exocytosis in human neutrophils through pertussis-toxin-sensitive and -insensitive signal transduction pathways.
MATERIALS AND METHODS Materials
The lipopeptides Pam3Cys-Ser (Prass et al., 1987) , Pam3Cys-Ser-Gly, Pam3Cys-Ala-Gly and Pam3Cys-Ser-(Lys)4 (Reitermann et al., 1989) , and the lipoamino acid Pam3Cys-OH (Wiesmuller et al., 1983) and its methyl ester Pam3Cys-OMe (Taufkirchen, Germany) . Recombinant human tumour necrosis factor-a (TNFa) was from Boehringer Mannheim (Mannheim, Germany). Sources of other materials have been described elsewhere (Seifert et al., 1986 (Seifert et al., , 1989a Seifert & Schultz, 1987a,b; Burde et al., 1989) .
Isolation of neutrophils
Human neutrophils were prepared as described previously in detail (Markert et al., 1984; Seifert et al., 1989b Assay for 02-generation 02 -formation was monitored at 550 nm by continuous measurement of ferricytochrome c reduction inhibitable by superoxide dismutase, using an Uvikon 810 dual-beam spectrophotometer (Kontron, Eching, Germany) (Markert et al., 1984; Seifert et al., 1989b) . Reaction mixtures (0.5 ml) contained 100 ,tM-ferricytochrome c and a buffer consisting of 138 mMNaCl, 6 mM-KCI, I mM-MgCl2, 1 mM-CaCI2, 5.5 mM-glucose and 20 mM-Hepes/NaOH, pH 7.4. Cells (1.0 x 106 neutrophils) were preincubated for 3 min in the absence or presence of various additives at 37 'C. 02-formation was initiated by the addition of the stimuli. Reference cuvettes contained all of the components listed above, plus superoxide dismutase (50,ug) .
Assay for lysozyme and f/-glucuronidase release Exocytosis was assessed as described (Absolom, 1986; Seifert et al., 1989c; Burde et al., 1989) . Briefly, neutrophils (5 x 106 cells) were incubated in buffer (0.5 ml) for 5 min in the presence of cytochalasin B (CBj (1 ,ug/ml). At 10 min after addition of stimuli, the tubes were cooled to 0 'C and were centrifuged for 10 min at 250 g. Determination of the activities of lysozyme, /Jglucuronidase and lactate dehydrogenase in the supernatant fluids of reaction mixtures and of cell lysates was performed as described (Absolom, 1986; Seifert et al., 1989c; Burde et al., 1989 Experiments were carried out in the presence of CB (1 #sg/ml). 0, Maximum rate of 02,-formation; *, total amount of02'-generated.
Data shown are the means + S.D. of three experiments.
Fig . 3 shows the concentration-response curve for activation of NADPH oxidase by Pam3Cys-Ser-(Lys)4. The experiments were carried out in the presence of CB, which potentiates receptor-mediated 02--formation by inhibiting sequestration of plasma membrane receptors (Jesaitis et al., 1986) . The lipopeptide activated 02;-formation in a concentration-dependent manner with respect to the maximum rate and the absolute amount of02.-generated. The effect of Pam3Cys-Ser-(Lys)4 was half-maximal at
60-70 ,ug/ml and reached a plateau at 100 ,ug/ml. In contrast, muramyl dipeptide and the lipopeptides Pam3Cys-OH, Pam3Cys-OMe, Pam3Cys-Ser, Pam3Cys-Ser-Gly and Pam3Cys-Ala-Gly at 1-100 ,ug/ml did not activate 02--formation in the absence or presence of CB (results not shown). Palmitic acid and lipopolysaccharide at 1-100 ,sg/ml did not activate 02-formation in suspended neutrophils (results not shown).
Activation of 02-formation by Pam3Cys-Ser-(Lys)4: role of G-proteins
In order to elucidate the role of G-proteins in the activation of 02-formation by Pam3Cys-Ser-(Lys)4, neutrophils were treated with pertussis toxin. Pertussis toxin inhibited 02-formation induced by fMet-Leu-Phe and Pam3Cys-Ser-(Lys)4 but not by phorbol 12-myristate 13-acetate (PMA), which circumvents receptor stimulation by activating protein kinase C directly (Fig.  4) . The inhibitory effect of pertussis toxin on fMet-Leu-Phe-and lipopeptide-induced 02--formation was half-maximal at 5-10 ng/ml and maximal at 1 /g/ml. Pertussis toxin completely abolished the stimulatory effect of fMet-Leu-Phe, whereas the effect of Pam3Cys-Ser-(Lys)4 was inhibited by up to 85 %. The effect of pertussis toxin on 02--formation was time-dependent. Half-maximal inhibition of fMet-Leu-Phe-and lipopeptideinduced 02.-formation was observed after 60-75 min of toxin treatment. Inhibition of chemotactic-peptide-induced 02-formation was complete after an incubation time of 3 h. Again, pertussis toxin did not completely abolish the stimulatory effect of Pam3Cys-Ser-(Lys)4 on 02' formation.
Synergistic activation of 02--formation by fMet-Leu-Phe and Pam3Cys-Ser-(Lys)4
The synergistic effects of fMet-Leu-Phe and Pam3Cys-Ser-(Lys)4 were studied in detail. The experiments shown in Fig as follows: A, PMA (100 ng/ml); *, 1 4aM-fMet-Leu-Phe plus CB (1 jg/ml); 0, Pam3Cys-Ser-(Lys)4 (100 jug/ml) plus CB (1 ,ug/ml). Data shown are the means + S.D. of six experiments. The inhibitory effect of pertussis toxin on Pam3Cys-Ser-(Lys)4-induced°2-formation was significant (P < 0.05 or P < 0.01) at toxin concentrations of 1-1000 ng/ml and incubation times of 1-3 h.
Vol. 267 and fMet-Leu-Phe in human neutrophils
The effects of fMet-Leu-Phe at various concentrations were studied in the presence of Pam3Cys-Ser-(Lys)4 at three fixed concentrations.
Experiments were carried out in the absence of CB. 0, Solvent (control); *, Pam3Cys-Ser-(Lys)4 (10 l g/ml); A, Pam3Cys-Ser-(Lys)4 (30 zg/ml); V, Pam3Cys-Ser-(Lys)4 (100 /Og/ml). The interaction of fMet-Leu-Phe and Pam3Cys-Ser-(Lys)4 was markedly affected by CB (results not shown). In the presence of CB, neutrophils generated 02-at similar rates upon exposure to fMet-Leu-Phe at 3 nM and to Pam3Cys-Ser-(Lys)4 at 100 ,ag/ml.
The lipopeptide and the chemotactic peptide at these concentrations activated 02 formation additively. However, with fMetLeu-Phe at a maximally stimulatory concentration (1 gM), no synergism with Pam3Cys-Ser-(Lys)4 was apparent. Table I summarizes the effects of various lipopeptides at 100 ltg/ml on fMet-Leu-Phe-induced 02.-formation in the absence of CB. In contrast with Pam3Cys-Ser-(Lys)4, the lipotripeptides Pam3Cys-Ala-Gly and Pam3Cys-Ser-Gly did not significantly affect 02;-formation, whereas Pam3Cys-Ser and Pam3Cys-OMe inhibited 02;-formation by up to 350% and Pam3Cys-OH inhibited 02.-formation by more than 75 %.
PMA, UTP, platelet-activating factor (PAF) and TNFa prime neutrophils for enhanced 02--formation upon exposure to fMetLeu-Phe (Dewald & Baggiolini, 1985; Tyagi et al., 1988; Seifert et al., 1989a,b,c; Yuo et al., 1989) . Therefore we compared the interaction of these priming agents with fMet-Leu-Phe and Pam3Cys-Ser-(Lys)4 (Table 2 ). Neither UTP nor TNFa per se induced 02--formation. PMA at 1 ng/ml induced°2 formation at a low rate, and PAF (1 /sM) activated 02' formation to an extent amounting to 300% of that induced by fMet-Leu-Phe (1 ,sM). PMA, TNFa, UTP and PAF interacted synergistically with fMet-Leu-Phe to activate 02-formation. In contrast, only PMA but not TNFa, UTP or PAF interacted synergistically with Pam3Cys-Ser-(Lys)4 to activate NADPH oxidase. The effects of various drugs on chemotactic peptide-and lipopeptide-induced 02--formation were compared (Table 3) .
Staurosporine, a potent inhibitor of protein kinases Ruegg & Burgess, 1989) , and the thiol reagent NEM abolished 02--formation induced by both Pam3Cys-Ser-(Lys)4 and fMet-Leu-Phe. The removal of extracellular Ca2+ decreased fMet-Leu-Phe-induced 02--formation by more than 800%, whereas the effect of Pam3Cys-Ser-(Lys)4 was diminished only by about 30 %. CB and R 59 022, the inhibitor of diacylglycerol kinase (de Chaffoy de Courcelles et al., 1985), enhanced chemotactic peptide-and lipopeptide-induced 02 formation by up to 2.5-fold.
02--formation induced by various receptor agonists is differen-
tially inhibited by the activators of adenylate cyclase, prostaglandin E1 (PGE1), isoprenaline, histamine and cholera toxin (Seifert et al., 1989a; Burde et al., 1989) . PGE1, isoprenaline and histamine inhibited fMet-Leu-Phe-induced 02-formation by up to 55 %, whereas the effect of Pam3Cys-Ser-(Lys)4 was inhibited by up to 850% (Table 4) . In agreement with a recent report, cholera toxin did not significantly inhibit fMet-Leu-Phe-induced 02--formation (Gabler et al., 1989) . In contrast, cholera toxin inhibited the effect of Pam3Cys-Ser-(Lys)4 by about 7000.
Activation of exocytosis by Pam3Cys-Ser-(Lys)4
The role of lipopeptides in the regulation of exocytosis was Table 4 . Inhibition by activators of adenylate cyclase of 02M-formation induced by fMet-Leu-Phe and Pam3Cys-Ser-(Lys)4 in human neutrophils
The effects of various activators of adenylate cyclase on 02-formation induced by fMet-Leu-Phe (1 #M) or Pam3Cys-Ser-(Lys)4 (100 /tg/ml) plus CB (1 ,ug/ml) were studied. PGE1, isoprenaline, histamine or solvent (control) were added to reaction mixtures 3 min before addition of stimuli. Cells were treated with cholera toxin or its vehicle for 3 h according to the procedure described in the legend to Fig. 4 The effects of fMet-Leu-Phe and of Pam3Cys-Ser-(LY6)4 and combination of both stimuli on lysozyme release in human neutrophils were studied. Vol. 267 Table 6 . Effect of pertussis toxin on exocytosis in human neutrophils induced by fMet-Leu-Phe and Pam3Cys-Ser-(Lys)4
Neutrophils were treated with pertussis toxin (PTX) at 1 ,ug/ml or its vehicle under the conditions described in the legend to Fig. 4 . Cells were preincubated with CB (1 jug/ml) for 3 min before the addition of stimuli or solvent (control). The concentrations of stimuli were as follows: fMetLeu-Phe, 1 /M; Pam3Cys-Ser-(Lys)4, lOO,10g/ml; A23187, 10 /SM. Effectiveness of stimuli to induce exocytosis in control cells: *P < 0.01. (Tables 5 and 6 ). Lysozyme is localized in the azurophilic and specific granules, and fl-glucuronidase is present only in the azurophilic granules (Absolom, 1986 ). Pam3Cys-Ser-(Lys)4 at 100 jug/ml induced lysozyme release to a similar extent as did the chemotactic peptide at 30 nm. In addition, the lipopeptide and fMet-Leu-Phe (30 nM) induced lysozyme release additively. However, fMet-Leu-Phe at 1 ,UM and Pam3Cys-Ser-(Lys)4 showed no additive effect on lysozyme release. Pam3Cys-Ser-(Lys)4 did not induce f,-glucuronidase release, suggesting that the lipopeptide induced only exocytosis of specific granules.
Human neutrophils were treated with pertussis toxin (I ,ug/ml) for 3 h (see Fig. 4 ). Pertussis toxin completely inhibited fMetLeu-Phe-induced ,-glucuronidase release and did not inhibit exocytosis induced by the Ca2+ ionophore, A23 187, which circumvents receptor stimulation by increasing the intracellular Ca2+ concentration directly. In addition, pertussis toxin inhibited fMet-Leu-Phe-induced lysozyme release by 75 %, whereas Pam3Cys-Ser-(Lys)4-induced exocytosis was not affected by the toxin treatment.
DISCUSSION
Similarities and dissimilarities between lipopeptides and other activators of neutrophils: role of plasma membrane receptors and G-proteins Lipoproteins are major constituents of bacterial cell walls (Braun, 1975) . We report here on the activation of 02-formation and lysozyme release in human neutrophils by the synthetic lipohexapeptide Pam3Cys-Ser-(Lys)4. The identification of a 35 kDa lipopeptide-binding protein in murine B-lymphocytes by Biesert et al. (1987) raises the possibility that activation of NADPH oxidase by Pam3Cys-Ser-(Lys)4 is mediated through specific binding proteins as well. In order to answer this question we compared activation of 02-formation by fMet-Leu-Phe and Pam3Cys-Ser-(Lys)4. Activation of NADPH oxidase by chemotactic peptides and lipopeptides has several characteristics in common, i.e. the ceasing of 02.-formation after some minutes, the (at least partial) dependency on extracellular Ca2 , sensitivity to NEM, pertussis toxin, activators of adenylate cyclase and staurosporine, and potentiation by PMA, CB and R 59022 ( Figs. 2 and 4 ; Tables 2-4). In addition, activation of 02--formation by lipopeptides shows specificity for the amino acid chain (see Table 2 ). These data suggest that activation ofNADPH oxidase by Pam3Cys-Ser-(Lys)4 is a receptor-mediated process which involves activation of pertussis-toxin-sensitive G-proteins.
How can the partial pertussis-toxin-sensitivity of lipopeptideinduced 02.-formation -and pertussis-toxin-insensitivity of lipopeptide-induced exocytosis ( Fig. 4; Table 6 ) be explained? It is well known that activation of human myeloid cells by various classes of receptor agonists, e.g. IgG, purine nucleotides and cytokines, shows partial pertussis-toxin-insensitivity (Blackburn & Heck, 1988; Dubyak et al., 1988; Richter et al., 1989; Seifert et al., 1989a) . These data suggest that receptors for these intercellular signal molecules interact, at least in part, with ADPribosylated G-proteins, and/or that pertussis-toxin-insensitive G-proteins are involved in the signal transduction pathway, including GTP-binding proteins with molecular masses of approx. 20 kDa (Bokoch & Parkos, 1988) . In addition, there is recent evidence that different types of receptors interact specifically with pertussis-toxin-sensitive or -insensitive G-proteins, ultimately leading to activation of the same effector system (Ashkenazi et al., 1989) . Furthermore, McLeish et al. (1989) reported that formyl peptide and leukotriene B4 receptors in human myeloid cells interact differently with G-proteins. Another explanation for the partial pertussis-toxin-insensitivity of the effects of Pam3Cys-Ser-(Lys)4 is outlined below.
There are some dissimilarities between O2-formation induced by chemotactic peptides and by Pam3Cys-Ser-(Lys)4, i.e. the differential sensitivity to pertussis toxin and cyclic AMPincreasing agents and dependency on extracellular Ca2+ (Fig. 4 ; Tables 3 and 4 ). In addition, TNFa, UTP and PAF prime neutrophils for fMet-Leu-Phe but not for Pam3Cys-Ser-(Lys)4 (see Table 2 ). Furthermore, the onset of Pam3Cys-Ser-(Lys)4-induced 02-formation is delayed, suggesting that the lipopeptide reaches its target of action more slowly than does fMet-Leu-Phe (see Fig. 2 ) (Seifert et al., 1989b) . Finally, the kinetics of synergistic activation of 02.-formation by fMet-Leu-Phe and UTP or PAF or Pam3Cys-Ser-(Lys)4 are quite different (Fig. 2 ) (Seifert et al., 1989b,c) , and UTP and PAF, but not Pam3Cys-Ser-(Lys)4, interacted synergistically with fMet-Leu-Phe when added to neutrophils after the chemotactic-peptide-induced 02.-formation had ceased ( Fig. 1 ; Dewald & Baggiolini, 1985; Seifert et al., 1989c) . These data suggest that activation of NADPH oxidase by lipopeptides involves mechanisms additional to those by which fMet-Leu-Phe, UTP and PAF activate this effector system. This assumption is also supported by our finding that Pam3Cys-Ser-(Lys)4, unlike fMet-Leu-Phe, does not induce ,-glucuronidase release (see Table 6 ).
There are some functional dissimilarities between lipopolysaccharide and lipopeptides with respect to NADPH oxidase regulation. First, lipopolysaccharide per se does not activate O2' formation in suspended neutrophils but only in adherent cells (Dahinden et al., 1983) , whereas Pam3Cys-Ser-(Lys)4 is effective in suspended neutrophils (see Fig. 2 ). Lipopolysaccharide primes neutrophils for enhanced O2-formation in a pertussis-toxin-insensitive manner (Forehand et al., 1989) . By contrast, the effects of lipopeptides on O2 --formation are, at least in part, pertussis-toxin-sensitive (Fig. 4) . In addition, the priming effect of lipopolysaccharide on 02;-formation becomes evident only with incubation times longer than 30 min, whereas the priming effect of Pam3Cys-Ser-(Lys)4 is evident immediately (Fig. 2) . These data indicate that lipopolysaccharide and lipopeptides are functionally non-equivalent and play different roles in the regulation of NADPH oxidase.
Structure-activity studies with lipopeptides
The analysis of the structure-activity relationship for lipopeptide-induced activation of 02--formation provides important information concerning the mode of action of these compounds (Table 1) . Among a variety of lipopeptides studied, Pam3Cys-Ser-(Lys)4 is the only one with stimulatory effects on neutrophils. In contrast, Pam3Cys-Ala-Gly and Pam3Cys-SerGly are inactive and Pam3Cys-Ser, Pam3Cys-OMe and Pam3Cys-OH are inhibitory. The difference between Pam3Cys-Ser-(Lys)4 and the other lipopeptides is that the former possesses four positively charged amino groups in the lysyl residues of the hexapeptide chain (see Fig. 1 ). Apparently these positive charges, which facilitate the interaction with negatively charged domains of phospholipids and proteins, are important for the stimulatory action of Pam3Cys-Ser-(Lys)4. In murine lymphocytes, Pam3Cys-Ser-(Lys)4, Pam3Cys-Ser and Pam3Cys-Ala-Gly are similarly effective cell activators, and Pam3Cys-OH and Pam3Cys-OMe are only weakly active (Bessler et al., 1985; Reitermann et al., 1989) . These data suggest that the interaction of lipopeptides with plasma membranes is cell-type-specific. There are some structural and functional similarities between Pam3Cys-Ser-(Lys)4 and the tetradecapeptide mastoparan, which is found in wasp venom. Both Pam3Cys-Ser-(Lys)4 and mastoparan are amphiphilic and bear positive charges (Fig. 1 ) (Higashijima et al., 1988) . Thus both molecules may cross the plasma membrane to reach intracellular targets of action. In addition, mastoparan mimicks certain aspects of agonist-induced cell activation (Okano et al., 1985; Wilson, 1989; Wojcikiewicz & Nahorski, 1989; Yokokawa et al., 1989) as does Pam3Cys-Ser-(Lys)4. Furthermore, Higashijima et al. (1988) have shown that mastoparan directly interacts with G-proteins, possibly by mimicking the effects of basic loops of plasma membrane receptors. Finally, studies with intact cells and purified G-proteins showed that mastoparan-induced activation of G-proteins is partially pertussis-toxin-resistant (Higashijima et al., 1988; Yokokawa et al., 1989) . By analogy, the effects of Pam3Cys-Ser-(Lys)4 on O2-formation are also partially resistant to inhibition by pertussis toxin (Fig. 4) , and its effects on lysozyme release are not inhibited by the toxin at all (Table 6 ).
Lipopeptides as potentiators of neutrophil activation
Anotho r aspect of neutrophil activation by Pam3Cys-Ser-(Lys)4 is its synergism with chemotactic peptides (Figs. 2 and 5 ; Tables 1 and 5 ). The synergism between the two classes of stimuli on 02-formation is still evident in the presence of the agonists at maximally stimulatory concentrations, suggesting that they activate neutrophils by different mechanisms. This assumption is supported by the differential sensitivity of lipopeptide-and chemotactic-peptide-induced 02-formation to various inhibitory drugs and by the different kinetics of O2'-formation (see Figs. 2 and 4; Tables 3 and 4). Pam3Cys-Ser-(Lys)4 primes neutrophils for fMet-Leu-Phe at non-stimulatory concentrations but does not substantially shift the concentration-response function to chemotactic peptide-induced 02-formation to the left, suggesting that it does not alter the affinity state of formyl peptide receptors. However, GB blunts synergistic interaction of Pam3Cys-Ser-(Lys)4 with fMet-Leu-Phe, indicating that the lipopeptide and CB act, at least in part, by a mechanism they have in common, i.e. by preventing receptor sequestration and by expressing new plasma membrane formyl peptide receptors (Jesaitis et al., 1986) . Additional mechanisms by which lipopeptides potentiate chemotactic-peptide-induced activation of NADPH oxidase may involve synergistic activation of stimulatory G-proteins, amplification of the activation of effector systems and generation of intracellular signal molecules, and translocation of cytosolic components of NADPH oxidase to the plasma membrane.
Physiological role of lipopeptides as activators of human neutrophils
Finally, what may be the physiological relevance of neutrophil activation by lipoproteins? As lipoproteins are present in Gramnegative bacteria, they would be expected to serve as intercellular signal molecules for neutrophils in inflammatory processes, as is the case for chemotactic peptides (Braun, 1975; Rossi, 1986; Malech & Gallin, 1987) . A major obstacle to the proper interpretation of experiments with purified lipoprotein is its potential contamination with small amounts of other bacterial products, e.g. lipopolysaccharide, and its poor solubility in aqueous media (Bessler et al., 1985) . These problems are overcome by the use of chemically synthesized lipopeptides containing the pure biologically active N-terminal moiety of native lipoproteins. Pam3Cys-Ser-(Lys)4 per se is a much less effective activator of 02--formation and exocytosis than fMet-Leu-Phe, but potentiates the effects of chemotactic peptides (Figs. 2 and 5; Table 5 ). These data suggest that lipopeptides function predominantly as priming agents, as do purine and pyrimidine nucleotides, PAF and TNFa (Table 3) . Apparently, all of these potentiators of neutrophil activation are functionally nonequivalent. Of potential physiological relevance is the finding that Pam3Cys-Ser-(Lys)4 induces the release of lysozyme which degrades murein, to which lipoproteins are covalently attached (Braun, 1975; Absolom, 1986) (Tables 5 and 6 ). Lipoproteininduced lysozyme release from neutrophils would thus provide a feed-forward signal for enhanced bactericidal activity, a process which is accompanied by an increased release of lipoprotein from bacteria.
It should be noted that the lipopeptides used in our present study, in particular Pam3Cys-Ser-(Lys)4, are not secretory products of Gram-negative bacteria. It is likely that lipopeptides bearing positively charged amino acids are released from native lipoprotein during its proteolytic degradation, but this process has not yet been studied (Braun, 1975) . The activation in vivo of 2--formation by chemotactic peptides is modulated substantially by various factors such as adherence and cytokines (Dahinden et al., 1983; Nathan, 1987) . In what way these factors may affect lipopeptide-induced 2--formation in vivo is not known. Thus at present it is difficult to finally assess the physiological relevance of neutrophil activation by lipopeptides.
In summary, we provide evidence that the synthetic lipopeptide Pam3Cys-Ser-(Lys)4 is a neutrophil activator which possesses properties both similar and dissimilar to other classes of neutrophil activators, suggesting that it activates neutrophils through a unique transmembrane signalling process. In addition, our data suggest that Pam3Cys-Ser-(Lys)4 may be a useful experimental tool to study activation of G-proteins in human neutrophils.
